Skip to main content

Table 1 Major clinical and laboratory characteristics of patients with multiple sclerosis included to the study

From: A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis

 

(n = 133)

Sex (M/F) (%)

40 (30.1%)/93 (69.9%)

Age (years) (mean ± SD)

42.7 ± 11.9

Age at diagnosis (years) (mean ± SD)

31.5 ± 10.4

(> 20/< 20 years)

132 (99.2%)/1(0.8%)

(> 30/< 30 years)

110 (82.7%)/23(17.3%)

(> 40/< 40 years)

72 (51.4%)/61(45.9%)

(> 50/< 50 years)

37 (27.8%)/96 (72.2%)

(> 60/< 60 years)

14 (10.5%)/119 (89.5%)

(> 70/< 70 years)

1 (0.8%)/132 (99.2%)

Type of MS (RRMS/SPMS/PPMS)(%)

102 (76.6%)/27 (20.3%)/4 (3%)

Duration (years) (mean ± SD)

11.2 ± 7.2

EDSS score

3.3 ± 2.1

Number of relapses

5 ± 3.6

Progression index

0.42 ± 0.56

  1. EDSS: Expanded Disability Status Scale score, RRMS: Relapsing–remitting Multiple Sclerosis, SPMS: Secondary Progressive Multiple Sclerosis, PPMS: Primary Progressive Multiple Sclerosis